Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BGLC OTCMKTS:GRST NASDAQ:MGRX NYSE:SSY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBGLCBioNexus Gene Lab$6.47-6.6%$4.38$2.01▼$15.60$12.45M5.313.47 million shs479,126 shsGRSTEthema Health$0.00-25.0%$0.00$0.00▼$0.00$3.09M1.912.77 million shs10,235 shsMGRXMangoceuticals$1.71+1.8%$1.80$1.32▼$7.66$8.68M2.4143,189 shs53,827 shsSSYSunLink Health Systems$1.04-2.8%$1.00$0.62▼$1.91$7.32M1.11137,328 shs46,642 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBGLCBioNexus Gene Lab-6.64%+32.04%-5.13%+140.52%+32.66%GRSTEthema Health-25.00%0.00%-25.00%0.00%-66.67%MGRXMangoceuticals+1.79%-1.16%+12.50%+1.79%-98.14%SSYSunLink Health Systems-2.80%-23.53%+12.68%+19.54%+16.99%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBGLCBioNexus Gene Lab0.3115 of 5 stars0.03.00.00.02.20.00.0GRSTEthema HealthN/AN/AN/AN/AN/AN/AN/AN/AMGRXMangoceuticalsN/AN/AN/AN/AN/AN/AN/AN/ASSYSunLink Health Systems1.6969 of 5 stars0.03.00.00.02.41.71.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBGLCBioNexus Gene Lab 0.00N/AN/AN/AGRSTEthema Health 0.00N/AN/AN/AMGRXMangoceuticals 0.00N/AN/AN/ASSYSunLink Health Systems 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBGLCBioNexus Gene Lab$9.51M1.22N/AN/A$4.63 per share1.40GRSTEthema Health$6.02M0.39N/AN/AN/A∞MGRXMangoceuticals$511.08K17.29N/AN/A$4.30 per share0.40SSYSunLink Health Systems$31.09M0.24N/AN/A$2.00 per share0.52Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBGLCBioNexus Gene Lab-$1.60MN/A0.00∞N/A-22.85%-24.18%-20.14%N/AGRSTEthema Health-$2.06MN/A0.00∞N/A-1.03%N/A-0.51%N/AMGRXMangoceuticals-$8.71M-$4.64N/A∞N/A-2,191.76%-72.81%-66.58%8/13/2025 (Estimated)SSYSunLink Health Systems-$1.53M$0.247.43∞N/A3.20%-20.94%-16.09%N/ALatest GRST, BGLC, MGRX, and SSY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025BGLCBioNexus Gene LabN/A-$0.03N/A-$0.03N/AN/A5/15/2025Q1 2025MGRXMangoceuticalsN/A-$1.29N/A-$1.29N/A$0.11 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBGLCBioNexus Gene LabN/AN/AN/AN/AN/AGRSTEthema HealthN/AN/AN/AN/AN/AMGRXMangoceuticalsN/AN/AN/AN/AN/ASSYSunLink Health SystemsN/AN/AN/AN/AN/ALatest GRST, BGLC, MGRX, and SSY DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/21/2025SSYSunLink Health Systemsspecial$0.107/29/20257/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBGLCBioNexus Gene LabN/A4.193.44GRSTEthema HealthN/A0.050.05MGRXMangoceuticalsN/A0.120.12SSYSunLink Health SystemsN/A4.063.62Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBGLCBioNexus Gene Lab18.85%GRSTEthema HealthN/AMGRXMangoceuticals56.72%SSYSunLink Health Systems23.67%Insider OwnershipCompanyInsider OwnershipBGLCBioNexus Gene Lab0.70%GRSTEthema Health55.75%MGRXMangoceuticals16.00%SSYSunLink Health Systems27.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBGLCBioNexus Gene Lab301.80 million1.78 millionNot OptionableGRSTEthema Health507.73 billion3.42 billionNot OptionableMGRXMangoceuticals35.17 million4.34 millionNot OptionableSSYSunLink Health Systems1,3767.04 million5.08 millionNot OptionableGRST, BGLC, MGRX, and SSY HeadlinesRecent News About These CompaniesSunLink Health Systems, Inc. Adjourns Special Meeting Until August 4, 2025 and Urges Stockholders of Record as of June 20, 2025 to Vote FOR the Proposed Merger With Regional Health Properties, Inc. by August 3, 2025 at 11:59 PM EDTJuly 29, 2025 | businesswire.comA Closer Look at SunLink’s (SSY) Special DividendJuly 26, 2025 | msn.comSunlink Health Systems Receives NYSE American Deficiency NoticeJuly 26, 2025 | theglobeandmail.comSunLink Health Systems updates on planned special cash dividendJuly 24, 2025 | msn.comSunLink Health Systems, Inc. provides an Update on Proxy Voting for the Proposed Merger with Regional Health Properties, Inc. and Urges Stockholders of Record as of June 20, 2025 to Vote FOR the Proposed Merger by July 28, 2025 at 11:59 PM EDTJuly 24, 2025 | businesswire.comSunLink Health Systems, Inc. Provides Update on Special Cash Dividend Scheduled to Be Paid Prior to SunLink's Proposed Merger with Regional Health Properties, Inc.July 24, 2025 | businesswire.comSunLink Health Systems, Inc Declares Special Cash Dividend Prior to with the Proposed Merger with Regional Health Properties, Inc.July 21, 2025 | businesswire.comSunLink Health Systems Declares 10c Special DivJuly 19, 2025 | marketwatch.comSunLink Health Systems Announces That It Received a NYSE American LLC Notice Indicating That SunLink Has Fallen Below Certain NYSE American Continued Listing ... - MorningstarJuly 8, 2025 | morningstar.comMSunLink Health Systems Announces That It Received a NYSE American LLC Notice Indicating That SunLink Has Fallen Below Certain NYSE American Continued Listing StandardsJuly 7, 2025 | businesswire.comSunlink Health Systems Extends Merger Agreement DeadlineJune 23, 2025 | tipranks.comSunLink Health Systems, Inc. Announces Fiscal 2025 Third Quarter ResultsMay 13, 2025 | businesswire.comREGIONAL HEALTH PROPERTIES AND SUNLINK HEALTH SYSTEMS REVISE ALL-STOCK MERGER TRANSACTIONApril 15, 2025 | markets.businessinsider.comSunLink Health Systems, Inc. Announces Fiscal 2025 Second Quarter ResultsFebruary 12, 2025 | businesswire.comRegional Health Properties to merge with Sunlink Health SystemsJanuary 8, 2025 | mcknightsseniorliving.comMRegional Health, SunLink Health to merge in all-stock transactionJanuary 7, 2025 | markets.businessinsider.comSunLink Health Systems Inc (SSY) Stock Trading RecapJanuary 7, 2025 | bovnews.comBRegional Health Properties Shares More Than Double on SunLink Health DealJanuary 6, 2025 | marketwatch.comShareholder Alert: Ademi LLP Investigates Whether SunLink Health Systems, Inc. Is Obtaining a Fair Price for Its Public ShareholdersJanuary 6, 2025 | stockhouse.comSSY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of SunLink Health Systems, Inc. Is Fair to ShareholdersJanuary 6, 2025 | tmcnet.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeGRST, BGLC, MGRX, and SSY Company DescriptionsBioNexus Gene Lab NASDAQ:BGLC$6.47 -0.46 (-6.64%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$6.56 +0.09 (+1.39%) As of 08/1/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.Ethema Health OTCMKTS:GRST$0.0003 0.00 (-25.00%) As of 08/1/2025 12:12 PM EasternEthema Health Corporation operates behavioral healthcare space specifically in the treatment of substance use disorders. It offers rehabilitation services. The company was formerly known as GreeneStone Healthcare Corporation and changed its name to Ethema Health Corporation in April 2017. Ethema Health Corporation is based in West Palm Beach, Florida.Mangoceuticals NASDAQ:MGRX$1.71 +0.03 (+1.79%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$1.68 -0.03 (-2.05%) As of 08/1/2025 05:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.SunLink Health Systems NYSE:SSY$1.04 -0.03 (-2.80%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.12 +0.09 (+8.17%) As of 08/1/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates in two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates a 49-licensed-bed acute care hospital, which includes a 26-bed geriatric psychiatry unit; two clinics; and a 66-bed extended care and rehabilitation centre. This segment also provides information technology services; and owns five acers unimproved lands. The Pharmacy segment offers institutional pharmacy services consisting of provision of specialty and non-specialty pharmaceutical and biological products, such as nursing homes, assisted living facilities, behavioural and specialty hospitals, hospices, and correctional facilities; non-institutional pharmacy services, including private residences; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services. SunLink Health Systems, Inc. was incorporated in 1959 and is based in Atlanta, Georgia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Why Bloom Energy Stock Could Break to New Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
